A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes

Female sexual dysfunction (FSD) is highly prevalent in women with diabetes mellitus (DM), yet it remains unaddressed, undiagnosed, and untreated. Hypoactive sexual desire disorder (HSDD) is the most common complaint among women with FSD, but there is a paucity of research into its multifactorial eti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochester-Eyeguokan, Charmaine, Meade, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630567/
https://www.ncbi.nlm.nih.gov/pubmed/28918588
http://dx.doi.org/10.1007/s13300-017-0313-0
Descripción
Sumario:Female sexual dysfunction (FSD) is highly prevalent in women with diabetes mellitus (DM), yet it remains unaddressed, undiagnosed, and untreated. Hypoactive sexual desire disorder (HSDD) is the most common complaint among women with FSD, but there is a paucity of research into its multifactorial etiology. Flibanserin is the only therapy approved by the US Food and Drug Administration for treating acquired, generalized HSDD in premenopausal women. Women with DM diagnosed with HSDD may require a multidisciplinary approach for optimal management.

Ejemplares similares